Ampio Pharmaceuticals, Inc. (Nasdaq: AMPE) announced that its wholly-owned subsidiary Vyrix Pharmaceuticals has filed a registration statement on Form S-1 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE